Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Monday, June 30, 2014

New Drug May Boost Survival for Advanced Prostate Cancer Patients: Study - Drugs.com MedNews

›
A pill that blocks male hormone activity can improve survival and delay the need for chemotherapy in men with advanced prostate cancer, a ...
Monday, June 23, 2014

New Drug May Treat Constipation Caused by Strong Painkillers - Drugs.com MedNews

›
A new drug holds promise as a safe and effective treatment for constipation caused by prescription narcotic painkillers, new research stat...
1 comment:
Friday, June 20, 2014

Green tea could reduce pancreatic cancer risk: Study explains how

›
A study  recently published online by the journal,  Metabolomics , offers an  explanation that researchers say could open a new area of ca...
Thursday, June 19, 2014

New drug for non-Hodgkin lymphoma, chronic lymphocytic leukemia passes early test

›
The drug, alisertib or MLN8237, inhibits the enzyme aurora A kinase, which is known to be very active during cell division. The present ...
Wednesday, June 18, 2014

Leptin also influences brain cells that control appetite, researchers find -- ScienceDaily

›
Twenty years after the hormone leptin was found to regulate metabolism, appetite, and weight through brain cells called neurons, Yale Scho...
Tuesday, June 17, 2014

New therapy for pancreatic cancer patients shows promising results -- ScienceDaily

›
New therapy for pancreatic cancer patients shows promising results  A Cinical trial conducted by researchers at the Virginia G. Piper ...
Monday, June 16, 2014

FDA Approves Incruse Ellipta...

›
GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved  Incruse Ellipta  (umeclidinium) as an ant...
Friday, June 13, 2014

FDA Approves Zontivity to Reduce the Risk of Heart Attacks and Stroke

›
The U.S. Food and Drug Administration  approved  Zontivity  ( vorapaxar ) tablets to reduce the risk of heart attack, stroke, cardiovascul...
Thursday, June 12, 2014

Amrubicin promise for etoposide-naïve SCLC patients

›
Patients with chemotherapy-refractory small-cell lung cancer (SCLC) may benefit from treatment with the topoisomerase II inhibitor amrubic...
Wednesday, June 11, 2014

Promising discovery in fight against antibiotic-resistant bacteria .....

›
Researchers at  the  University  of British  Columbia  have identified a small molecule  that prevents  bacteria from forming into biofilm...
Tuesday, June 10, 2014

New details on microtubules and how the anti-cancer drug Taxol works

›
A pathway to the design of even more effective versions of the powerful anti-cancer drug Taxol has been opened with the most detailed look...
Monday, June 9, 2014

Isis Pharmaceuticals reports positive data from ISIS-GCGRRx Phase 2 study in patients with type 2 diabetes

›
Isis Pharmaceuticals, Inc.  announced positive data from a Phase 2 study of ISIS-GCGR Rx  in patients with type 2 diabetes uncontrolled on...
Saturday, June 7, 2014

Probiotics prevent deadly complications of liver disease, study finds -- ScienceDaily

›
Probiotics are effective in preventing hepatic encephalopathy in patients with cirrhosis of the liver, according to a new study in  Clinica...

Researchers identify drugs to slow progression of idiopathic pulmonary fibrosis

›
Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with n...
1 comment:
Friday, June 6, 2014

Novel drug for patients with inoperable CTEPH shows improvement in international trial

›
After a year of being treated with a novel drug, patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and those ...
‹
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.